Seattle Genetics meldet Zahlen für 2018
- 2018 Umsatz ~655 Mio. $ (vgl. 482 Mio. $ in 2017)
- 2018 Verlust ~223 Mio. $ (vgl. 126 Mio. $ in 2017)
2019 FINANCIAL OUTLOOK
Seattle Genetics anticipates 2019 total revenues to be in the range of $790 million to $840 million, driven by the following components:
ADCETRIS net product sales | $610 million to $640 million | ||||
Collaboration and license agreement revenues | $95 million to $110 million | ||||
Royalty revenues | $85 million to $90 million |